Dyne Therapeutics, Inc. - Common Stock (DYN)

Dyne Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for patients with serious muscle diseases, particularly those caused by genetic mutations

The company leverages its proprietary Dynamic™ approach to design and deliver targeted medicines that can modulate gene expression and address the underlying causes of these conditions. By utilizing advanced technologies, Dyne aims to provide transformative treatment options that enhance the quality of life for individuals affected by muscle disorders, while also advancing its pipeline of therapeutic candidates through various stages of development.